Bandingkan Harga & Kinerja Era Mandiri Cemerlang Tbk. (IKAN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Era Mandiri Cemerlang Tbk. dan Organon Pharma Indonesia Tbk.: Era Mandiri Cemerlang Tbk. diperdagangkan di Rp90 (kapitalisasi pasar 75,83 M, volume 24 jam 8,23 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| IKAN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 75,83 M | 104,4 M |
Volume | 8,23 jt | — |
Lot | 82,29 rb | — |
Perputaran | 741,24 jt | — |
Harga Rata-rata | 90,07 | — |
Nilai Transaksi | 741,24 jt | — |
Harga Ekuilibrium Indikatif | 90 | — |
Volume Ekuilibrium Indikatif | 311 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Era Mandiri Cemerlang Tbk.
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Selengkapnya di halaman IKAN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
